"While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review

Placenta. 2021 Dec:116:31-37. doi: 10.1016/j.placenta.2021.02.010. Epub 2021 Feb 25.

Abstract

Distinction of hydatidiform moles (HM) from non-molar (NM) specimens and subclassification of HM as complete hydatidiform mole (CHM) versus partial hydatidiform mole (PHM) are important for clinical practice and investigational studies. The issue of diagnostic reproducibility is still unsolved, the lack of diagnostic accuracy based on morphology is substantial with an important interobserver variability, even between experienced gynecologic pathologists. Many ancillary techniques have been investigated in the last years to refine HM diagnosis. p57 (a paternally imprinted, maternally expressed gene) immunohistochemistry, based on the unique genetics of CHM (purely androgenetic), PHM (diandric triploid), and NM specimens (biparental, with allelic balance) can identify CHMs, which lack p57 expression because of a lack of maternal DNA. However, although its role in HM diagnosis is pivotal, it does not allow the distinction of PHM from NM specimens, both of which express p57 due to the presence of maternal DNA. Molecular genotyping, which compares villous and decidual DNA patterns to determine the parental source and ratios of polymorphic alleles, distinguishes purely androgenetic CHM from diandric triploid PHM, and both of these from NM specimens. Beyond the claim of establishing a "diagnostic truth", exceptions and peculiar genetic scenarios in the origin of rare CHM and PHM should be kept in mind when approaching any ancillary technique. An algorithmic approach, even in settings with limited resources, can help the pathologists in the diagnostic dilemma of diagnosis of first trimester abortions.

Keywords: Complete hydatidiform mole; Diagnostic algorithm; First trimester abortion; Molar pregnancies; Molecular genotyping; Partial hydatidiform mole; p57.

Publication types

  • Review

MeSH terms

  • Cyclin-Dependent Kinase Inhibitor p57 / genetics
  • Cyclin-Dependent Kinase Inhibitor p57 / metabolism*
  • Diagnosis, Differential
  • Female
  • Genotype
  • Humans
  • Hydatidiform Mole / diagnosis*
  • Hydatidiform Mole / metabolism
  • Pregnancy
  • Pregnancy Trimester, First
  • Uterine Neoplasms / diagnosis*
  • Uterine Neoplasms / metabolism

Substances

  • Cyclin-Dependent Kinase Inhibitor p57